Back to search results

Observational Study on Post-Operative Trigeminal Pain After Microvascular Decompression

This observational study is looking at the long-term effects of microvascular decompression (MVD) surgery for trigeminal neuralgia (TN). Researchers want to understand if dental treatments or other face-related stimulation after MVD surgery might increase the chance of pain returning. You might be eligible if you are an adult who has already had MVD for Type I Trigeminal Neuralgia. The study will track how well your pain is controlled for up to 60 months (5 years) after surgery. The study is currently unclear on its recruitment status and aims to include 100 participants.

Study design
This is an observational study, meaning researchers will gather information from participants who have already had MVD surgery. It plans to enroll 100 participants.
What's involved
You would be asked to complete surveys over the phone about your pain experiences, anxiety, and any dental or facial treatments you've had.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for pain control for up to 60 months (5 years) after their surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07216547

Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia

Not Yet Recruiting
Not specifiedAges 18+Observational
Rutgers, The State University of New Jersey
~100 participants
Updated 2025-10-14 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain control following microvascular decompression (MVD)
Measured over Up to 60 months post-surgery

Conditions

Trigeminal Neuralgia
Microvascular Decompression Surgery
Post-operative Pain

Explore related trials

Trigeminal neuralgia

NCT07216547

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Rutgers School of Dental Medicine

    Newark, New Jerseystudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Gary Heir, DMD · PRINCIPAL_INVESTIGATOR · Rutgers School of Dental Medicine

Who to contact

Sowmya Akkineni, BDS
[email protected]
540-408-7645
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

MVD post-operative patients with type I Trigeminal Neuralgia.

Exclusion

Atypical (Type II) Facial Pain at presentation, revision surgery.
Patients who are unable or unwilling to provide informed consent will be excluded from the study.

What this trial measures

  • Pain control following microvascular decompression (MVD)Up to 60 months post-surgery

    Pain control will be assessed using the Barrow Neurological Institute (BNI) Pain Scale to evaluate changes in pain severity and relief after MVD.